Clinical Trials
2 trialsNCT01480154 2026-04-13
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT01144169 2016-10-26
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
University of Pittsburgh
Phase 1 Terminated